The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABSCI CORPORATION | COM | 00091E109 | BBG011N54DC3 | 246,230 | 21,245 | SH | OTR | 1 | 0 | 21,245 | 0 | |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | BBG001T8R687 | 126,505,652 | 3,408,937 | SH | OTR | 1 | 0 | 3,408,937 | 0 | |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | BBG001V1GPQ9 | 186,648 | 10,100 | SH | OTR | 1 | 0 | 10,100 | 0 | |
| BOLT BIOTHERAPEUTICS INC | COM NEW | 097702203 | BBG00N8MY5W8 | 118,580 | 30,800 | SH | OTR | 1 | 0 | 30,800 | 0 | |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | BBG00BV2Y9C6 | 34,215,647 | 7,326,691 | SH | OTR | 1 | 0 | 7,326,691 | 0 | |
| CG ONCOLOGY INC | COM | 156944100 | BBG00YHKK4R2 | 2,230,331 | 31,391 | SH | OTR | 1 | 0 | 31,391 | 0 | |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | BBG00HW2DGR3 | 163,225,335 | 8,963,500 | SH | OTR | 1 | 0 | 8,963,500 | 0 | |
| DENALI THERAPEUTICS INC | COM | 24823R105 | BBG008P7F878 | 299,844 | 11,658 | SH | OTR | 1 | 0 | 11,658 | 0 | |
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | BBG00MTSMC25 | 1,314,540 | 178,606 | SH | OTR | 1 | 0 | 178,606 | 0 | |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | BBG00Z83VS56 | 66,100 | 10,000 | SH | OTR | 1 | 0 | 10,000 | 0 | |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | BBG00HFZPB97 | 300,549 | 61,588 | SH | OTR | 1 | 0 | 61,588 | 0 | |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | BBG011BQC422 | 356,517,181 | 13,263,288 | SH | OTR | 1 | 0 | 13,263,288 | 0 | |
| IMMATICS N.V | SHS | N44445109 | BBG00VTL2J09 | 235,381 | 23,236 | SH | OTR | 1 | 0 | 23,236 | 0 | |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | BBG005TP2348 | 40,600 | 20,000 | SH | OTR | 1 | 0 | 20,000 | 0 | |
| KORRO BIO INC | COM | 500946108 | BBG00GFMTC47 | 20,274,741 | 1,538,296 | SH | OTR | 1 | 0 | 1,538,296 | 0 | |
| NEUPHORIA THERAPEUTICS INC | COM | 64136E102 | BBG01RFZ8667 | 3,825,183 | 875,328 | SH | OTR | 1 | 0 | 875,328 | 0 | |
| NUVATION BIO INC | COM CL A | 67080N101 | BBG00VHJ0CD0 | 91,045 | 16,029 | SH | OTR | 1 | 0 | 16,029 | 0 | |
| PASSAGE BIO INC | COM NEW | 702712209 | BBG00NBK4XG8 | 3,287,942 | 673,759 | SH | OTR | 1 | 0 | 673,759 | 0 | |
| PLIANT THERAPEUTICS INC | COM | 729139105 | BBG00C8083P2 | 2,049,800 | 1,798,070 | SH | OTR | 1 | 0 | 1,798,070 | 0 | |
| PRECISION BIOSCIENCES INC | COM NEW | 74019P207 | BBG008NSBPW2 | 7,470,663 | 950,466 | SH | OTR | 1 | 0 | 950,466 | 0 | |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | BBG006N8B849 | 969,828 | 521,413 | SH | OTR | 1 | 0 | 521,413 | 0 | |
| STOKE THERAPEUTICS INC | COM | 86150R107 | BBG00JPCBPH8 | 132,136,579 | 4,038,404 | SH | OTR | 1 | 0 | 4,038,404 | 0 | |
| TRAWS PHARMA INC | COM NEW | 68232V884 | BBG001T921M7 | 471,801 | 559,470 | SH | OTR | 1 | 0 | 559,470 | 0 | |
| TSCAN THERAPEUTICS INC | COM | 89854M101 | BBG00PH1N025 | 7,859,567 | 8,019,148 | SH | OTR | 1 | 0 | 8,019,148 | 0 | |
| VYNE THERAPEUTICS INC | COM | 92941V308 | BBG00H5W8GN7 | 1,059,795 | 1,628,700 | SH | OTR | 1 | 0 | 1,628,700 | 0 | |
| WEREWOLF THERAPEUTICS INC | COM | 95075A107 | BBG00QXQ9XL3 | 236,737 | 657,786 | SH | OTR | 1 | 0 | 657,786 | 0 | |
| XENCOR INC | COM | 98401F105 | BBG0026ZG4X9 | 292,923 | 18,194 | SH | OTR | 1 | 0 | 18,194 | 0 | |